Detalhe da pesquisa
1.
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Cell
; 173(3): 611-623.e17, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656891
2.
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell
; 173(3): 581-594.e12, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656895
3.
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Immunity
; 46(4): 577-586, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28410988
4.
Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis.
J Hepatol
; 75(1): 177-189, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631227
5.
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
Support Care Cancer
; 28(2): 561-570, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089820
6.
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecol Oncol
; 153(3): 541-548, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005287
7.
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.
Nature
; 493(7432): 406-10, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242139
8.
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.
BMC Cancer
; 18(1): 1292, 2018 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591028
9.
Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.
Gynecol Oncol
; 149(2): 275-282, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454514
10.
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
J Pathol
; 241(3): 362-374, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859259
11.
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Lancet Oncol
; 18(8): 1009-1021, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28694034
12.
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.
Cancer Immunol Immunother
; 66(1): 113-117, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838762
13.
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
BMC Cancer
; 17(1): 456, 2017 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28666422
14.
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).
Gynecol Oncol
; 144(2): 405-413, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27931752
15.
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.
BJU Int
; 119(6): 846-853, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27981711
16.
Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment.
Gynecol Oncol
; 142(1): 190-198, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27079213
17.
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.
Gynecol Oncol
; 142(1): 62-69, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27103175
18.
Two cases of gallbladder metastasis from renal cell carcinoma and review of literature.
World J Surg Oncol
; 14: 87, 2016 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27005674
19.
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
N Engl J Med
; 366(10): 883-892, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22397650
20.
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
Gynecol Oncol
; 139(2): 216-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318078